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Abstract
Subtilase (SubAB) is a cytotoxin elaborated by some Shiga Toxin (Stx)-producing Escherichia coli (STEC) strains usually lacking the locus of
enterocyte effacement (LEE). Two variants of SubAB coding genes have been described: subAB1, located on the plasmid of the STEC O113
98NK2 strain, and subAB2, located on a pathogenicity island (PAI) together with the tia gene, encoding an invasion determinant described in
enterotoxigenic E. coli. In the present study, we determined the entire nucleotide sequence of the PAI containing the subAB2 operon, termed
Subtilase-Encoding PAI (SE-PAI), and identiﬁed its integration site in the pheV tRNA locus. In addition, a PCR strategy for discriminating the
two subAB allelic variants was developed and used to investigate their presence in E. coli strains belonging to different pathotypes and in a large
collection of LEE-negative STEC of human and ovine origin. The results conﬁrmed that subAB genes are carried predominantly by STEC and
showed their presence in 72% and 86% of the LEE-negative strains from human cases of diarrhoea and from healthy sheep respectively. Most
of the subAB-positive strains (98%) identiﬁed possessed the subAB2 allelic variant and were also positive for tia, suggesting the presence of SE-
PAI. Altogether, our observations indicate that subAB2 is the prevalent SubAB-coding operon in LEE-negative STEC circulating in European
countries, and that sheep may represent an important reservoir for human infections with these strains. Further studies are needed to assess
the role of tia and/or other genes carried by SE-PAI in the colonization of the host intestinal mucosa.
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Introduction
Subtilase (SubAB) is an AB5 toxin produced by certain
Escherichia coli strains associated with human disease [1].
SubAB is composed of a 35 kDa A subunit displaying a
subtilase-like serine protease activity and ﬁve 13 kDa B
subunits forming a pentamer, which mediates the binding to
speciﬁc receptors on the host cell surface [1]. Following
internalization in cultured cells, SubAB is delivered to the
endoplasmic reticulum (ER) [2], where it has been demon-
strated to cleave the chaperone BiP [3], causing the RNA-
dependent protein kinase-like ER kinase activation and the
transient inhibition of protein synthesis, resulting in the
induction of the apoptotic signalling pathways [4–7].
SubAB has so far been identiﬁed almost exclusively in Shiga
toxin (Stx)-producing E. coli (STEC), and in particular in strains
that do not possess the locus for enterocyte effacement (LEE)
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[8–18]. The LEE is a pathogenicity island (PAI) governing the
attaching and effacing mechanism of intestinal adhesion [19],
and represents a common feature of STEC strains associated
with severe human disease. It has been hypothesized that the
SubAB may contribute to the pathogenesis of STEC-associated
human disease by playing a synergistic role with Stx [2]. As a
matter of fact, SubAB has been shown to induce, in a mouse
model, the typical haemolytic uraemic syndrome (HUS)-
associated features caused by Stx, such as extensive micro-
vascular damage, and thrombosis and necrosis in the brain,
kidneys and liver [20].
The prototype SubAB-positive STEC strain 98NK2, belong-
ing to serotype O113:H21 and isolated from an outbreak of
HUS in South Australia [1], carries the subtilase-coding operon
(subAB) on a large virulence plasmid designated as pO113,
which also carries the saa gene, encoding an autoagglutinating
adhesin possibly involved in the colonization of the host
intestinal mucosa [21].
Recently, we reported the production of SubAB by two Stx-
negative E. coli strains (ED 32 and ED 591), isolated from two
unrelated cases of uncomplicated diarrhoea in Italy [22].
Genetic analyses showed that the nucleotidic sequences of the
subA and subB genes were identical in the two strains and 90%
similar to those of the corresponding genes present in the
pO113 plasmid of strain 98NK2 [22]. Strains ED 32 and ED
591 were both LEE-negative and did not react in a saa-speciﬁc
PCR assay. Moreover, differently from strain 98NK2, they
harboured the subAB genes in the chromosome and next to
another gene, tia, encoding an invasion factor previously
described in enterotoxigenic E. coli (ETEC) [23]. An identical
chromosomal region carrying subAB and tia was identiﬁed in
the chromosome of other subAB-positive STEC strains [22],
suggesting the existence of a putative pathogenicity island (PAI)
vehiculating the subAB and tia virulence genes.
The presence of subAB genes among E. coli strains of human
or animal origin has been investigated in several studies [8–18].
However, most of these studies did not involve the use of
tools capable of distinguishing between the two allelic variants
of the subAB gene. As an exception, a recent investigation
conducted on STEC strains isolated from cattle, sheep and
goats [14] reported a different distribution of the two subAB
variants in the different animal species, with the subAB98NK2,
named by the authors subAB1, associated with bovine strains,
and subABED32, termed subAB2, more frequent among strains
from small ruminants [14].
In the present work, we investigated the presence of the
two allelic variants of the SubAB gene in human E. coli strains
belonging to different pathotypes and in a large collection of
LEE-negative STEC of human and ovine origin. Moreover, we
determined the entire nucleotidic sequence of the putative PAI
containing the subAB2 operon in the prototype E. coli strain ED
32 and describe its gene content and insertion site.
Materials and Methods
Bacterial strains
The prototype E. coli strain ED 32, containing the subAB2 allelic
variant, is part of the culture collection of the Istituto
Superiore di Sanita and has been previously described [22].
The panel of human strains investigated included 177 STEC
strains belonging to 10 different serogroups and displaying
different combinations of stx-coding genes, 26 enteropatho-
genic E. coli (EPEC), 32 enterotoxigenic E. coli (ETEC), 20
enteroaggregative E. coli (EAEC), 13 enteroinvasive E. coli
(EIEC), all isolated from cases of diarrhoea, and one strain
isolated from a urinary tract infection (uropathogenic E. coli,
UPEC).
The diarrhoeagenic E. coli used in this study have been
classiﬁed based on the presence of the virulence genes
described to be associated to the different pathotypes in the
literature. EPEC pathotype was identiﬁed by the presence of
the intimin-coding eae gene, detected together with the
plasmid-associated marker EAF for identifying typical EPEC.
STEC were recognized by the presence of the stx1 and stx2
genes. The invasion plasmid antigen-coding gene ipaH and the
enteroaggregative E. coli antiaggregation protein transporter
gene aat (previously reported as CVD 432) were considered
markers for EIEC and EAEC pathotypes respectively. Finally,
ETEC strains were identiﬁed by the presence of the heat-
stable and the heat-labile enterotoxin-coding genes (est and elt,
respectively). All the virulence genes were ampliﬁed as
previously described [22]. The PCR assay for the gene
encoding the EAF determinant has been described in [24].
The only human UPEC was isolated from a patient suffering
from urinary tract infection. Serotyping, including both O and
H antigen identiﬁcation, was performed by the WHO Collab-
orating Centre for Reference and Research on Escherichia and
Klebsiella at the Statens Serum Institut (Copenhagen, Den-
mark).
All the STEC strains selected for this study lacked the eae
gene, considered as a hallmark for the presence of the LEE
locus. All the E. coli strains of human origin included in the
study are part of the Statens Serum Institut (Copenhagen,
Denmark) culture collection.
One hundred and twenty-three LEE-negative STEC strains
isolated from sheep were included in the study. The strains
had been isolated from healthy animals in Spain during a
previous longitudinal study involving 12 different sampling visits
(one sampling/month) at four different farms. All the animal
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isolates are part of the culture collection held at the University
of Extremadura (Caceres, Spain).
Construction of a genomic library from the ED 32 strain
A genomic library of strain ED 32 was constructed by using a
Lambda ZAP II predigested EcoRI/CIAP-treated vector kit
(Stratagene, La Jolla, CA, USA), following the supplier’s
instructions. In detail, 200 ng of total DNA were extracted
from strain ED 32 (PureGene; Gentra Systems, Big Lake, MN,
USA), partially digested with the EcoRI restriction enzyme, and
ligated with 1 lg of the vector by incubation with 2 units of
DNA ligase for 18 h at 4°C. Two lL of the Gigapack III gold
packaging extract (Stratagene) were added to the ligase
reaction mixture and incubated at room temperature for
2 h. Following addition of 500 lL of SM buffer (5.8 g/L NaCl,
2.0 g/L MgSO4 7H2O, 50 mM Tris-HCl (pH 7.5), 0.01% (wt/
vol) gelatin) and 20 lL of chloroform, the supernatant
containing the phages was titrated in E. coli XL1-Blue MRF’
host bacteria. Ampliﬁcation of the library was performed to
obtain a ﬁnal titre of 1.5 9 109 PFU/mL.
Identiﬁcation of the subAB-ﬂanking regions in the ED 32
strain
The sequence of the chromosomal regions ﬂanking the subAB
and tia genes in strain ED 32 was determined by using two
different approaches. As the tia gene associated with subAB2
shared 90% of sequence identity with the homologous gene in
the ETEC strain IAI39, the region downstream this gene was
obtained by PCR using the primer tRNA_phe_anchor designed
on the available genomic sequence of this latter strain
(GenBank Acc. No. CU928164), in combination with the
subA_anchor primer, deployed on the sequence of the ED 32
strain subA gene (Fig. 1 and Table 1). The ampliﬁcation
reaction was conducted on a total DNA preparation from
strain ED 32 and gave an ampliﬁcation product of about
6,600 bp, which was subjected to sequencing.
The DNA sequence of the region located downstream the
subAB operon was determined by sequencing the insert of a
clone identiﬁed by screening the ED 32 library with a DNA
probe corresponding to the 3′ terminal part of the subB gene
obtained by PCR ampliﬁcation using the subBendF/subBendR
primer pair (Table 1) [22 and this study].
Evaluation of the activity of the two variants of SubAB by
Vero cell assay
To investigate the possible differences in the activity of the two
SubAB variants, their ability of inducing CPE onto Vero cell
monolayers was compared by Vero cell assay (VCA). The
culture supernatant from the E. coli strains ED 186 and ED 32,
producing the SubAB1 and SubAB2 respectively, was assayed
by inoculating serial dilutions, up to 1:1024, onto Vero cell
monolayers in microtitre plates. As the ED 186 strain also
produced the Stx1, each dilution of the culture supernatant
from this strain was neutralized by incubation with an antibody
raised against Stx1, at a working titre of 1:200, before
inoculation. The VCA was conducted as previously described
TABLE 1. PCR primers used in this study for the characterization of the SubAB-encoding PAI, for the detection of subAB, tia and
saa, and for identifying the two allelic variants of the subAB operon
Primer name Gene target Sequence GenBank accession number (nucleotide position) Reference
RTsubABF subA 5′-GCAGATAAATACCCTTCACTTG-3′ AF399919 (13856-13835) 1
RTsubABR subB 5′-ATCACCAGTCCACTCAGCC-3′ AF399919 (13625-13643) 1
tia lo tia 5′-TCCATGCGAAGTTGTTATCA-3′ U20318 (577-558) 22
tia up tia 5′-GAAATGAAAAAGATTATTGCGG-3′ U20318 (7-28) 22
SubAF subA 5′-GTACGGACTAACAGGGAACTG-3′ AF399919 (14944-14964) 1
subA_anchor subA 5′-CATGACGTGAGGCAATGAGT-3′ JQ994271 (6565-6545) This study
tRNA_phe_anchor tRNAphe 5′-ATTGAAAATCCCCGTGTCCT-3′ CU928164 (4802156-4802137) This study
subA_startF subA 5′-CCCTGTAACATATTGACCAGCA-3′ JQ994271 (6208-6230) This study
subB_end_F subB 5′-GGCCTTCGTTTTCCACATTA-3′ JQ994271 (7550-7570) This study
subB_end_R subB 5′-TTATGAGTTCTTTTTCCTGTCAGG-3′ AF399919 (13283-13306) 22
saa up saa 5′-CGTGATGAACAGGCTATTGC-3′ AF399919 (7712-7731) 25
saa lo saa 5′-ATGGACATGCCTGTGGCAAC-3′ AF399919 (7830-7811) 25
Sulfatase Integrase 
pheV yjhS shiA tia subA subB 
RTsubAB_R 
RTsubAB_F 
subA_anchor 
Hydrolase_anchor tRNA_phe_anchor subBendF 
subBendR 
subA_startF 
ORF 1 ORF 3 
144 1328 1627 2700 3131 4438 4726 5472 6262 7305 7322 7744 
FIG. 1. Map of the Subtilase-Encoding Pathogenicity Island (SE-PAI), spanning the 8058 bp situated between the pheV tRNA locus and the E. coli
gene yjhS. The ORFs and the annotated genes, together with their positions in the PAI sequence, are shown (GenBank Acc. No. JQ994271). The
locations of the primers used to characterize SEPAI are also indicated.
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[22] and the CPE observed at 24, 48 and 72 h after inoculation.
The subAB genes from the two strains were also cloned in the
pGEM-T-Easy vector and used to transform the K-12 strain
JM109. The subAB operons were cloned together with their
native promoters to allow the expression of the subtilase.
Serial dilutions of overnight culture supernatants of the K-12
strains containing the cloned subAB operons were inoculated
onto Vero cell monolayers after sonication of the culture to
facilitate the release of the toxin produced and analysed in
parallel with the wild-type strains in the same conditions.
PCR screening for the presence of subAB, saa and tia genes
The presence of subAB was assessed using the primer pair
RTsubABF/RTsubABR [1], which allows the detection of both
the allelic variants [22]. The subAB operon from the positive
strains was typed using the primer pairs SubAF/RTsubABR [this
study and 1] and subA_startF/RTsubABR [this study and 1], able
to speciﬁcally detect the prototype subAB (subAB1) or the allelic
variant present in the ED 32 strain (subAB2) respectively. The
presence of saa and tia genes was assessed as previously
described [22]. All the primers used are listed in Table 1.
Nucleotide sequence accession number
The DNA sequence of the 8,058 bp DNA stretch spanning the
complete sequence of the PAI vehiculating subAB in the E. coli
strain ED 32 was submitted into GenBank with the Acc. No.
JQ994271. Annotation was made through the Glimmer online
tool (http://www.ncbi.nlm.nih.gov/genomes/MICROBES/glim
mer_3.cgi) and the predicted open reading frames were anal-
ysed with the blastp algorithm using the tool available at
NCBI (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi?PROGRAM=
blastp&BLAST_PROGRAMS=blastp&PAGE_TYPE=Blast
Search&SHOW_DEFAULTS=on&LINK_LOC=blasthome) in
order to investigate the closest informative matches (Table 2).
All the nucleotidic alignmentswere carriedoutwith the blastn
algorithm using the tool available at NCBI (http://www.ncbi.
nlm.nih.gov/blast/Blast.cgi?PROGRAM=blastn&BLAST_PRO-
GRAMS=megaBlast&PAGE_TYPE=BlastSearch&SHOW_
DEFAULTS=on&LINK_LOC=blasthome).
Results
Characterization of the genomic locus harboring the subAB2
operon in strain ED 32
The nucleotidic sequence of the genomic island vehiculating the
subAB2 operon in strain ED 32, partially described in a previous
study, was completed and the structure of the locus is
schematically reported in Fig. 1. Sequence analysis showed that
the locus, thatwe termed Subtilase-Encoding PAI (SE-PAI), spans
the 8 kb region between the E. coli gene yjhS, located 314 bp
downstream of the subAB2 operon, and the pheV tRNA locus,
situated 4,725 bp from the end of the tia gene (Fig. 1). The latter
DNA region contains an unnamed gene encoding a sulphatase,
the shiA gene, whose product is involved in the attenuation of the
Shigella ﬂexneri-induced inﬂammatory response, and the genetic
determinant for an integrase, probably involved in the PAI
mobilization machinery (Table 2). Downstream the subAB2
operon, SE-PAI, ends before the yjhS gene, which is part of an
operon, named yjhATS or nanCMS, encoding factors involved in
the internalization and catabolism of sialic acids. Such an operon
was described in both commensal and pathogenic bacteria and is
also present in the E. coli K12 reference strain MG1655
(GenBank Acc. No. NC000913). Therefore, it was considered
as the downstream boundary of SE-PAI.
The whole sequence of the SE-PAI has been searched for
homology with the records of the nucleotidic sequences,
including the whole genomes, stored in GenBank, with the aim
of investigating the variability of the ORFs and intergenic
sequences of the PAI. Three contigs deriving from whole
genome sequencing projects of STEC (E. coli 1.2264, Acc. No.
AEZO02000028; E. coli DG131-3, Acc. No AFDV01000051;
E. coli 9.0111, Acc. No. AEZZ02000022) contained the
complete DNA sequence of the SE-PAI. In all the cases the
sequences with a coverage of more than 90% shared between
97% and 99% of sequence similarity with the one identiﬁed in
the prototype strain ED 32, indicating a conserved structure
for this PAI. Interestingly, the STEC strains fully sequenced
were isolated from small ruminants (E. coli 1.2264 and E. coli
TABLE 2. Summary of ORFs in SE-PAI of the ED 32 strain identiﬁed by signiﬁcant similarity (BLASTP search)
ORF# Location in SE-PAI
Denomination
in SE-PAI Closest informative protein match
Homologues
Acc. No.
Aminoacidic
(AA) identities
Positive
AA substitutions
1 144-1328 integrase site-speciﬁc recombinase, phage integrase family
[Escherichia coli 99.0741]
ZP_11999107 394/394 (100%) 394/394 (100%)
2 1627-2700 shiA putative homolog to shiA (SHI-2 pathogenicity island of
Shigella ﬂexneri) [Escherichia coli IAI39]
CAR19509 320/353 (91%) 332/353 (94%)
3 3131-4438 sulphatase sulphatase family protein [Escherichia coli STEC_DG131-3] ZP_12260098 431/435 (99%) 432/435 (99%)
4 4726-5472 tia tia invasion determinant [Escherichia coli 1.2264] ZP_11990814 247/248 (99%) 248/248 (100%)
5 6262-7305 subA subtilase family protein [Escherichia coli STEC_EH250] EGW88118 347/347 (100%) 347/347 (100%)
6 7322-7744 subB subtilase cytotoxin subunit B [Escherichia coli] ACV40235 140/140 (100%) 140/140 (100%)
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DG131-3) and from a human case of infection (E. coli 9.0111).
The alignment was also conducted against the whole sequence
of the pO113 plasmid from the STEC O113:H21 strain EH 41
(Acc. No. NC_007365) and involved the entire SE-PAI and the
DNA region downstream of the subAB2 genes, corresponding
to the E. coli yjhATS operon. The analysis showed that no DNA
regions from the PAI or the ﬂanking region were present in the
plasmid harbouring the prototype subAB1 allele.
Comparative analysis of the activity of the two SubAB
variants
The Vero cell assays, conducted to evaluate possible differ-
ences in the activity of the two SubAB variants, showed that
the Subtilase cytotoxin produced by both the alleles was able
to induce the CPE up to a dilution of 1:128. This observation is
in line with previous descriptions for the product of subAB2
allele. Comparable results were also obtained for the two
SubAB variants when the supernatant of the K12 strains
containing the subAB recombinant plasmids was used in the
VCA. In this latter case, however, the effect on the cells was
visible only up to a dilution of 1:32, possibly caused by a lower
efﬁciency of expression in the transformants compared with
the wild-type strains.
Presence of the subAB genes in human pathogenic E. coli
The presence of subAB genes was investigated in a panel of 107
E. coli strains belonging to six different pathotypes and isolated
from cases of human disease (Table 3). The association of
subAB with LEE-negative STEC has previously been assessed in
several investigations [10, 22, 24], therefore only STEC strains
lacking the eae gene were selected for this study. The
screening was carried out by PCR using a set of oligonucle-
otides (RTsubABF/RTsubABR, Table 1) able to prime the
ampliﬁcation of both the subAB allelic variants and revealed the
presence of subAB genes in nine out of the 15 STEC (60%) and
one of the 32 ETEC (3%) strains tested. All the strains
belonging to the other pathotype were negative. The subAB-
positive STEC belonged to eight of the ten serogroups tested
(Table 3), and all possessed the subAB2 variant, with the
exception of one strain, which did not react with the primer
pairs speciﬁc for the two subAB variants. No association
between the presence of speciﬁc stx-gene types and the
presence of subAB could be established (data not shown).
Detection and characterization of the subAB locus in LEE-
negative STEC from human cases of diarrhoea
On the basis of the results obtained in the preliminary
screening, 162 additional LEE-negative STEC from human cases
of diarrhoea and belonging to the ten serogroups previously
tested were selected and assayed by PCR for the presence of
the two allelic variants of subAB, tia and saa (Table 4). The
subAB genes were detected in about 72% of the strains, and the
subAB2 variant was present in 98.3% of the positive isolates.
The subAB2 genes were always associated with tia, with the
exception of ﬁve O91 strains. An O181 strain was positive for
both subAB and tia, but did not react in the primers speciﬁc for
the two subAB variants, suggesting that additional subAB alleles
may exist. Finally, an O91 strain was positive for both the
subAB1 and subAB2 variants, as well as for the saa and tia genes,
suggesting the concomitant presence of the SE-PAI and a
plasmid similar to that described in the prototype O113 strain
98NK2. All the other strains were negative for saa.
PCR ampliﬁcation of tia yielded a 600 bp product in the
majority of the positive isolates, as expected on the basis of
the published sequence of the reference ETEC strain IAI39
(GenBank Acc. No. U20318). A 1.8 kb PCR fragment was
observed for 21 strains (19 O128, one O91 and one O146).
This amplicon size is consistent with the presence of a 1.2 kb
IS2 element interrupting the tia sequence, as has been
previously described in strain ED 591 (GenBank Acc. No.
FJ664545). Two additional strains (one O91 and one O146)
TABLE 3. Results of the PCR analyses for the presence of
subAB in human E. coli strains belonging to different patho-
types (tEPEC, typical EPEC; aEPEC, atypical EPEC)
E. coli pathotype
(No. of strains)
Serogroup
(No. of strains)
No. of subAB-positive
strains (allelic variant)
STEC (15) O76 (1) 1 (subAB2)
O78 (1) 1 (subAB2)
O91 (2) 1 (subAB2)
O113 (1) 1 (subAB2)
O117 (2) 0
O128 (2) 2 (subAB2)
O146 (2) 1 (subAB2)
O174 (1) 0
O181 (1) 1 (untypeable)
Orough (2) 1 (subAB2)
tEPEC (3) O119 (2) 0
O145 (1) 0
aEPEC (23) O8 (1) 0
O26 (2) 0
O55 (2) 0
O103 (3) 0
O111 (1) 0
O114 (1) 0
O119 (1) 0
O125 (1) 0
O127 (1) 0
O128 (3) 0
O145 (3) 0
O157 (4) 0
ETEC (32) O nta (1) 0
O6 (3) 0
O8 (3) 0
O25 (4) 0
O44 (1) 0
O153 (4) 0
O164 (1) 0
Orough (15) 1 (subAB2)
EAEC (20) O25 (1) 0
O92 (2) 0
O+b (17) 0
EIEC (13) O121 (1) 0
O nta (12) 0
UPEC (1) O102 (1) 0
ant: not tested.
bO+: the O antigen is present but couldn’t be typed.
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yielded both the 600 bp and 1.8 kb amplicons, suggesting the
presence of two copies of tia, one of them possibly interrupted
by the IS2 element.
Detection and characterization of the subAB locus in LEE-
negative STEC from healthy sheep
The high prevalence of the subAB2 variant in LEE-negative
STEC isolated from patients with diarrhoea prompted us to
investigate the possible animal reservoir of such E. coli strains.
As the presence of the subAB2 allele has been previously
reported in small ruminants, a panel of 123 LEE-negative STEC
isolated from sheep and belonging to 10 different serogroups
was examined for the presence of the two subAB variants, as
well as for tia and saa genes. The presence of subAB genes was
detected in 108 strains (87.8%), all but two possessing the
subAB2 variant (Table 5). The latter two strains belonged to
serogroups O6 and O123 and did not react with the primer
pairs speciﬁc for the two subAB variants, further supporting the
existence of additional subAB alleles.
As observed for the human strains, most of the subAB2-
positive ovine isolates (81.5%) were also positive for tia. The
19 tia-negative strains belonged to serogroups O166 (14
strains), O91 (three strains), O76 (one strain) and O176 (one
strain). None of the strains was positive in the saa-speciﬁc PCR
assay.
Discussion
Since their ﬁrst description, SubAB-coding genes have been
mainly detected in LEE-negative STEC [8–18], with the
exception of two E. coli strains that did not produce Stx
[22]. In the latter strains, the subtilase was encoded by an
allelic variant of the subAB genes, termed subAB2, which shared
90% homology with the prototype genes, subAB1, identiﬁed in
the virulence plasmid of the LEE-negative O113 STEC strain
98NK2 [2]. The subAB2 operon was located on the chromo-
some, in a putative PAI that contained also the gene tia,
encoding an invasion determinant described in ETEC [23]. In
the present study, we completed the sequence of this putative
PAI, which we termed SE-PAI, and showed that it is composed
of an 8 kb DNA region inserted downstream the pheV-tRNA
locus in the chromosome of strain ED 32. Beside subAB2 and
tia, SE-PAI carries another virulence gene, the Shigella ﬂexneri
gene shiA, whose product has been described to attenuate the
host inﬂammatory response induced by Shigella ﬂexneri infec-
tions [26]. The observation that SE-PAI is inserted close to the
pheV-tRNA locus opens the way for speculations on the
evolution of subAB-positive STEC strains. This locus represents
a hot-spot for the integration of PAIs in different bacterial
pathogens, such as the she PAI of S. ﬂexneri 2a [27] and PAI
IIAL862 of the extraintestinal pathogenic E. coli strain AL862
[28]. Moreover, this locus represents the insertion site of the
LEE PAI in many STEC strains, including those belonging to
serotype O103:H2, one of those most commonly associated
with severe disease in humans [1]. It could be hypothesized
that the LEE-negative, SE-PAI-positive STEC may have arisen
from a mutual exclusion event between this PAI and the LEE,
which might have competed for the same integration site. This
hypothesis could explain the strong association of the subAB2
operon with LEE-negative STEC and its apparent absence in
LEE-positive strains.
Thus far, little was known about the presence of the two
subAB allelic variants among STEC. Recently, a study conducted
TABLE 4. Results of the PCR analyses for the presence of the
subAB allelic variants, tia and saa, in LEE-negative STEC
strains of human origin
Genotype No. of strains positive for
Serotype stx1 stx2
No. of
strains subAB subAB2 tia subAB1 saa
O76:H19 + – 10 10 10 10 0 0
O78:H- + – 3 3 3 3 0 0
O78:H- + + 1 1 1 1 0 0
O91:H- + – 11 1 1 0 0 0
O91:H- – + 1 1 1 1 0 0
O91:H- + + 30 30 29 25 1a 1a
O113:H4 + + 6 5 5 5 0 0
O117:H7 + – 15 0 – – – –
O117:H- + – 4 0 – – – –
O128:H2 – + 27 26 26 26 0 0
O128:H2 + + 4 4 4 4 0 0
O146:H21 + + 26 24 24 24 0 0
O146:H28 – + 5 2 2 2 0 0
O146:H28 + + 2 2 2 2 0 0
O174:H21 – + 4b 0 – – – –
O181:H16 + – 3 3 2 3 0 0
Orough:H- + – 6 1 1 1 0 0
Orough:H- + + 4 4 4 4 0 0
Total 162 117 115 111 1 1
aOne single strain was positive for subAB1, subAB2, saa and tia simultaneously.
bThe strains have not been tested for the subAB variants, tia and saa, being negative
to the subAB screening assay (see text for details).
TABLE 5. Results of the PCR analyses for the presence of the
subAB allelic variants, tia and saa, in LEE-negative STEC
strains isolated from healthy sheep
No. of strains positive for
Serotype No. of strains subAB subAB2 tia subAB1 saa
O5 11 8 8 8 0 0
O6 7 5 4 5 0 0
O76 12 12 12 11 0 0
O87 10a 0 – – – –
O91 26 26 26 23 0 0
O123 5 5 4 5 0 0
O128 6 6 6 6 0 0
O146 19 19 19 19 0 0
O166 14 14 14 0 0 0
O176 13 13 13 12 0 0
Total 123 108 106 89 0 0
aThe strains have not been tested for the subAB variants, tia and saa, being negative
in the subAB screening assay (see text for details).
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on different animal species reported a high prevalence of
subAB2 among LEE-negative strains isolated from small rumi-
nants [14]. In that study, the discrimination between the two
allelic variants was based on the intensity of the bands obtained
by a non allele-speciﬁc PCR ampliﬁcation of the subAB genes,
with more intense bands identifying subAB1 and faint bands
suggesting the presence of subAB2 [14]. Another recent study
reported that 12 subAB-positive O128:H2 STEC strains from
different sources were all positive for tia [16], suggesting the
presence of the subAB2-harbouring SE-PAI.
We adopted a PCR-based strategy for the speciﬁc detection
of the two allelic variants of subAB to investigate their presence
in a vast collection of E. coli strains isolated from human and
animal sources. The screening of a panel of strains isolated
from cases of human disease and belonging to different
pathotypes conﬁrmed that subAB genes are mainly conﬁned to
STEC lacking the LEE locus. A further screening of a larger
collection of LEE-negative STEC strains isolated from patients
with diarrhoea showed that the subAB genes were present in
more than 70% of the isolates, thus supporting the hypothesis
that SubAB may play a role in the disease caused by these
STEC strains [1]. Interestingly, almost all the subAB-positive
strains were positive for the subAB2 variant, and the concom-
itant presence of tia suggests that the Subtilase-coding genes
were carried by SE-PAI.
The high prevalence of the subAB2 variant observed in
human LEE-negative STEC prompted us to investigate the
possible sources of such pathogenic E. coli. As the association
of subAB2 with STEC from small ruminants has been previously
suggested [14], we examined a large collection of LEE-negative
STEC isolated from sheep by using the same allele-speciﬁc
PCR strategy. The presence of subAB genes was observed in
86% of the strains and, similarly to the human isolates, all the
strains possessed the subAB2 allelic variant with the exception
of two untypeable strains. Again, most subAB2-positive strains
(84%) were also positive for tia, suggesting the presence of SE-
PAI.
Altogether, these observations indicate that subAB2 repre-
sents the prevalent allelic variant in the SubAB-positive, LEE-
negative STEC either colonizing sheep or causing diarrhoea in
humans, at least among the strains circulating in European
countries.
The subAB2 operon was also present in one ETEC strain.
This ﬁnding may be related to the presence of tia in SE-PAI. As
a matter of fact, the tia gene was ﬁrstly described as a virulence
gene of ETEC [23], suggesting that SE-PAI may have risen as a
mosaic structure through recombination events involving
ETEC, before being stably acquired by LEE-negative STEC.
The high prevalence of subAB2 genes in STEC of ovine origin
suggests that sheep may represent an important animal
reservoir of subAB2-positive, LEE-negative STEC and conﬁrms
the zoonotic origin of these human infections. Further studies
are needed to (i) assess the role of other ruminant species in
the epidemiology of these infections and (ii) elucidate whether
tia and/or other genes carried by SE-PAI may be involved in the
colonization of the host intestinal mucosa by subAB2-positive
STEC, acting as an alternative to the attaching and effacing
machinery.
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